analyst

NASDAQ · FHTX
Foghorn Therapeutics Inc.
Healthcare · Biotechnology
$2.00
Down-$0.03 (-1.50%)
Updated Oct 6, 2026, 10:34 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 252.77M
- P/E ratio
- -3.73
- Dividend yield
- 0.00%
- 52-week range
- $1.79 – $7.61
- Volume
- 987.96K
- Avg. volume
- 207.49K
Price performance · FHTX
FHTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
FHTX closed at $2.00 after 20 trading sessions, down 58.59% for the selected period.
- Last close
- $2.00
- Period change
- -58.59%
- Period low
- $2.00
- Period high
- $4.83
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $2.03 | $2.12 | $1.98 | $2.00 | 987.96K |
| Oct 2, 2026 | $2.91 | $2.91 | $1.99 | $2.02 | 2.55M |
| Oct 1, 2026 | $2.08 | $3.21 | $1.79 | $2.92 | 13.38M |
| Sep 30, 2026 | $3.55 | $3.60 | $3.50 | $3.57 | 419.96K |
| Sep 29, 2026 | $3.53 | $3.58 | $3.46 | $3.52 | 376.22K |
| Sep 28, 2026 | $3.49 | $3.62 | $3.40 | $3.52 | 337.37K |
| Sep 25, 2026 | $3.61 | $3.66 | $3.465 | $3.50 | 525.43K |
| Sep 24, 2026 | $3.83 | $3.85 | $3.55 | $3.60 | 518.52K |
| Sep 23, 2026 | $4.12 | $4.21 | $3.85 | $3.87 | 1.8M |
| Sep 22, 2026 | $4.21 | $4.32 | $4.15 | $4.24 | 328.89K |
| Sep 21, 2026 | $4.16 | $4.19 | $4.07 | $4.15 | 188.41K |
| Sep 18, 2026 | $4.21 | $4.25 | $4.07 | $4.14 | 502.03K |
| Sep 17, 2026 | $4.27 | $4.3244 | $4.13 | $4.20 | 246.01K |
| Sep 16, 2026 | $4.17 | $4.23 | $4.08 | $4.17 | 354.92K |
| Sep 15, 2026 | $4.35 | $4.3799 | $4.09 | $4.12 | 467.62K |
| Sep 14, 2026 | $4.415 | $4.56 | $4.33 | $4.36 | 399.65K |
| Sep 11, 2026 | $4.54 | $4.62 | $4.37 | $4.42 | 289.13K |
| Sep 10, 2026 | $4.65 | $4.65 | $4.46 | $4.49 | 396.83K |
| Sep 9, 2026 | $4.79 | $4.895 | $4.66 | $4.67 | 199.62K |
| Sep 8, 2026 | $4.81 | $4.91 | $4.66 | $4.83 | 219.64K |
Latest FHTX news
The latest Smart Investors Daily articles mentioning FHTX.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

